We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel Method Identifies Pathogens in Bone Marrow Smears

By LabMedica International staff writers
Posted on 09 Jun 2015
Image: Bone marrow aspiration showing Histoplasma capsulatum (A) and the yeast stained with Periodic Acid Schiff reagent (B) (Photo courtesy of Gareth Gregory and Rose Linda).
Image: Bone marrow aspiration showing Histoplasma capsulatum (A) and the yeast stained with Periodic Acid Schiff reagent (B) (Photo courtesy of Gareth Gregory and Rose Linda).
The rapid identification of four pathogens and the early diagnosis of the four different diseases are of great importance; however some pathogens have a similar size and shape in the Wright‑Giemsa staining of bone marrow smears.

A novel method has been developed to rapidly identify the pathogens Penicillium marneffei, Histoplasma capsulatum, Mucor, and Leishmania donovani in bone marrow smears that can lead to the diseases penicilliosis marneffei, histoplasmosis, mucormycosis, and leishmaniasis, respectively.

Clinical laboratory scientists at Guangxi Medical University (Nanning, China) obtained 55 bone marrow smears (BMS) that were infected. There were 25 invaded by P. marneffei, 10 with H. capsulatum, 3 with Mucor, and 17 infected by L. donovani. The diagnosis of the four diseases was confirmed by pathogen culture. Each BMS was fixed by 95% alcohol for 10 minutes, prior to being washed, dried, stained by 1% periodic acid for 20 minutes and washed and dried once more. Each BMS was then stained by a Schiff reagent for 60 minutes, washed and dried, and subsequently stained by hematoxylin for five minutes, washed and dried. The BMSs were observed using light microscopy. Wright‑Giemsa staining was also performed, following standard protocols.

In the Wright Giemsa staining, the four pathogens were approximately the same size and mainly existed in macrophages. The multiplying P. marneffei had two nuclei, which were on both sides of the fungus, and had light cross walls in the middle. H. capsulatum had a purplish nucleus, which occupied between one third and one half of the spore. The cytoplasm was light blue. Peripheral spores were observed in the form of an empty, bright ring without color, like a capsule.

Generally Mucor were observed to have a long and lightly stained area, which could be confused with the Wright staining of dinuclear P. marneffei. L. donovani exhibited a deep staining kinetoplast near the nucleus. In the Periodic Acid Schiff (PAS) staining, the pathogens of P. marneffei and H. capsulatum were distinct and stained red.

The authors concluded that their staining method was simple and can enable the rapid diagnosis of penicilliosis marneffei, histoplasmosis, mucormycosis and visceral leishmaniasis. Furthermore, the method may have an important role in diag-nosing the four diseases in cases in which it is not possible to conduct pathogen culture and serology tests. The study was published in the May 2015 issue of the journal Experimental and Therapeutic Medicine.

Related Links:

Guangxi Medical University 


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more